Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, Renal Insufficiency Trial in United States (vildagliptin, sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • Mobile, Alabama
  • +86 more
Dec 11, 2020

Diabetes, Type 2 Trial in United States (vildagliptin, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +78 more
Dec 11, 2020

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin 10mg then Placebo Oral Tablet, Placebo Oral Tablet then Dapagliflozin 10mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dapagliflozin 10mg then Placebo Oral Tablet
  • Placebo Oral Tablet then Dapagliflozin 10mg
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Sep 15, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Glendale, Arizona
  • +87 more
Aug 10, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes, Type 2, Hypertension Trial in San Antonio (Matching Placebo, IW-1973)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Hypertension
  • San Antonio, Texas
    ICON Early Phase Unit
Apr 14, 2020

Diabetes, Type 2, Non-Alcoholic Fatty Liver Disease Trial in Canada, United States (BFKB8488A, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Non-Alcoholic Fatty Liver Disease
  • Anniston, Alabama
  • +17 more
Mar 25, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +118 more
Jan 8, 2020

Diabetes, Type 2 Trial in San Antonio (NNC0113-2023, Placebo (NNC0113-2023))

Completed
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Jan 8, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Muscle Shoals, Alabama
  • +142 more
Nov 8, 2019

Diabetes, Type 2 Trial in United States (Cyclo-Z, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +19 more
Nov 15, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/insulin aspart
  • +2 more
  • Glendale, Arizona
  • +70 more
Nov 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +208 more
Oct 2, 2019

Diabetes, Type 2 Trial in Worldwide (LY2409021, Sitagliptin, Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +32 more
Sep 25, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin Glargine
  • Fresno, California
  • +68 more
Sep 6, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Type 2 Trial in San Antonio (Saxagliptin, Dapagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Jul 22, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Type 2 Trial in United States (Lyophilized albiglutide DCC pen injector, Lyophilized albiglutide DCC pen injector

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lyophilized albiglutide DCC pen injector
  • +3 more
  • Birmingham, Alabama
  • +69 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019